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Prosolve, a new directly compressible vehicle 
consists of microcrystalline cellulose (98%) 
and colloidal silicon dioxide (2%). Piroxicam 
(20 mg) tablets, celecoxib (100 mg) tablets and 
aceclofenac (100 mg) tablets were formulated 
employing prosolve and three super 
disintegrants namely pregelatinised starch, 
sodium starch glycolate and croscarmellose 
sodium by direct compression method with a 
view to enhance their dissolution rate. In the 
micromeritic evaluation microcrystalline 
cellulose and its blends with other tablet 
ingredients exhibited excellent to good flow 
needed for direct compression. All the tablets 
formulated employing prosolve fulfilled the 
Pharmacopoeial standards with regard to 
various tablet characters. These tablets also 
gave 2 to 5 fold increase in the dissolution rate 
when compared to commercial tablets. Among 
the three disintegrants sodium starch glycolate 
gave higher dissolution rates when compared 
with both pregelatinised starch and 
croscarmellose sodium.  
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 Great interest in direct compression as a 
method of manufacture of tablets has been evident 
in recent years and this has resulted in a wide range 
of direct compression tablet formulations being 
introduced. Several directly compressible vehicles 
with good free flow and compaction properties have 
been developed in recent years. Prosolve is one such 
recently developed directly compressible vehicle. 
Prosolve, also known as silicified microcrystalline 
cellulose consists of microcrystalline cellulose 
(98%) and colloidal silicon dioxide (2%). Prosolve 
has improved compaction properties in both wet 
granulation and direct compression methods 
compared to conventional microcrystalline cellulose 
[1, 2]. The objective of the present study is to 
formulate and evaluate piroxicam and aceclofenac 
tablets employing Prosolve by direct compression 
method for enhancing their dissolution rates. 
Piroxicam, celecoxib and aceclofenac are widely 
prescribed non-steroidal anti inflammatory and 
analgesic drugs. They are practically insoluble in 
water and aqueous fluids. The poor aqueous 
solubility of these drugs gives rise to difficulty in 
the formulation of solid dosage forms such as 
tablets, leads to low and variable dissolution rate 
and bioavailability. Direct compression method 
employing prosolve was tried to enhance the 
dissolution rate of piroxicam, celecoxib and 
aceclofenac.  
Mintong Guo  et al (2003) investigated the 
SMCC’s performance to that of other excipients 
commonly used in hard gelatin capsule direct-fill 
formulations. All capsules were filled using a fully 
instrumented Zanasi LZ-64 automatic capsule-
filling machine. Four grades of SMCC [SMCC 50, 
SMCC 90, SMCC HD90, and an experimental-
grade (SMCC X)] were studied. Anhydrous lactose 
(direct tableting grade), pregelatinized starch (PGS) 
(Starch 1500), and microcrystalline cellulose (MCC) 
(Emcocel 90M) were chosen as the control fillers. 
Capsules were evaluated for capsule fill weight, 
relative standard deviation of capsule fill weight, 
plug ejection force, plug maximum breaking force 
(MBF), and the dissolution of two marker 
compounds (acetaminophen and piroxicam). 
Formulations containing 5% piroxicam, 30% 
acetaminophen, or 50% acetaminophen exhibited 
faster drug dissolution when MCC or SMCC was 
the filler than when anhydrous lactose or PGS was 
the filler. The data suggest that SMCC could be a 
suitable direct-fill excipient for hard shell capsule 
formulations [3] 
Ahmad Aljaberi  et al (2009) studied the 
silicified microcrystalline cellulose (SMCC), 
microcrystalline cellulose (MCC), and physical 
mixture of MCC–colloidal silicon dioxide 
(MCC/CSD at 98:2 ratio) as extra granular 
compression aids to address the processing and 
dissolution stability issues of this formulation. The 
compactibility and stickiness upon compression 
over extended period of time as well as the 
dissolution of R411 formulations incorporating the 
aforementioned compression aids were investigated. 
In addition, the water sorption/desorption properties 
of these compression aids were determined. The 
formulations containing SMCC provided superior 
dissolution stability over the other compression aids 
evaluated in the study. Novel functionalities of 
SMCC are presented in terms of sticking prevention 
while having the most beneficial effect on 
dissolution stability in R411 formulation [4]. 
 Piroxicam (20 mg), celecoxib (100mg) and 
aceclofenac (100 mg) tablets were formulated 
employing prosolve and three disintegrants namely 
pregelatinised starch, sodium starch glycolate and 
croscarmellose sodium by direct compression 
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Materials 
Piroxicam, celecoxib and aceclofenac 
were gift samples from M/s. Aristo Pharmaceuticals 
Ltd., Mumbai. Prosolve was a gift sample from M/s. 
Orchid Health Care Ltd., Chennai. Pregelatinised 
starch, sodium starch glycolate and croscarmellose 
sodium were procured from commercial sources. 




Preparation of tablets 
 Piroxicam (20 mg), celecoxib (100mg) 
and aceclofenac (100 mg) tablets were prepared 
employing prosolve by direct compression method 
as per the formulae given in Table 1. All the 
ingredients were blended thoroughly in a closed 
HDPE bottle and were directly compressed into 
tablets to a hardness of 6-8 kg/cm2 on a 16-station 
Cadmach tablet machine using 9 mm round and flat 
punches. All the tablets prepared were evaluated for 
drug content, hardness, friability, and disintegration 
time and dissolution rate. Hardness of the tablets 
was tested by using a Monsanto Hardness Tester. 
Friability of the tablets was determined in a Roche 
Friabilator. Disintegration time was determined in a 
Thermonic tablet Disintegration Test machine using 
water as test fluid.  
Estimation of drug content 
Drug content of the prepared tablets was 
estimated by UV Spectrophotometric method based 
on the measurement of absorbance at 333 nm in the 
case of Piroxicam tablets, 254 nm in the case of 
celecoxib and at 275 nm in the case of aceclofenac 
tablets. The methods were validated for linearity, 
precision and accuracy. The methods obeyed Beer’s 
law in the concentration range 1-10 g/ml. The 
accuracy and precision of the methods were in the 
range of 0.4 - 0.8 %. No interference from the 
excipients used was observed [6-7].  
 
Dissolution rate study 
 Dissolution rate of drug from the prepared 
and commercial tablets was studied using 8 - station 
Dissolution Rate Test Apparatus (LABINDIA, 
DISSO 2000) employing a paddle stirrer at 50 rpm 
and 37±0.50C. Hydrochloric acid (0.1 N), water 
containing 1% sodium lauryl sulphate and 
phosphate buffer of pH 7.4 were used as dissolution 
fluid (900 ml) respectively for piroxicam, celecoxib 
and aceclofenac tablets. Samples of  5 ml each were  
withdrawn at 5, 10, 20, 30, 40, 50 and 60 minutes 
and assayed at 333 nm in the case of piroxicam, 254 
nm in the case of celecoxib and 275 nm in the case 
of aceclofenac using Shimadzu UV-150 double 
beam UV-spectrophotometer. Each sample with 
drawn was replaced with an equal amount of fresh 
dissolution medium. For comparison, dissolution 
rate of commercial tablets in each case was also 
studied. Dissolution rate experiments were 
conducted in triplicate [5]. 
Dissolution data analysis 
 Dissolution data were analyzed as per zero 
and first order kinetic models. Dissolution 
efficiency (DE30) values were calculated as 
described by Khan6 and T50 (time for 50% 
dissolution) values were recorded from the percent 
dissolved vs. time plots and the data is appended in 
Table 2. 
Micromeritic evaluation 
 The flow characteristics of tablet 
granulations (i.e. blend of powders before 
compression) were assessed in each case by 
measuring the angle of repose by fixed funnel 
method and Carr’s compressibility index by 
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TABLE 1 




F1 F2 F3 F4 F5 F6 F7 F8 F9 
Piroxicam 20 20 20 - - - - - - 
Celecoxib - - - 100 100 100 - - - 
Aceclofenac - - - - - - 100 100 100 
Pg. starch 30 - - 30 - - 30 - - 
SSG - 10 - - 10 - - 10 - 
Croscarmellose 
sodium 
- - 10 - - 10 - - 10 
Lactose - 20 20 - - - - - - 
Prosolve 142 142 142 100 120 120 100 120 120 
Talc 4 4 4 4 4 4 4 4 4 
Magnesium stearate 4 4 4 4 4 4 4 4 4 
Total Weight of  
Tablet (mg) 
200 200 200 238 238 238 238 238 238 
 
 
TABLE 2  
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       TABLE 3    
            MICROMERITIC PROPERTIES OF PROSOLVE AND                                      
          ITS TABLET GRANULATIONS 
Formulation 






































RESULTS AND DISCUSSION 
 Piroxicam (20 mg), celecoxib (100 mg) 
and aceclofenac (100 mg) tablets were formulated 
employing prosolve, a new directly compressible 
vehicle by direct compression method. Angle of 
repose and compressibility index of prosolve as 
such and tablet granulations before compression 
were measured to assess their suitability for direct 
compression. The results of micromeritic evaluation 
are given in Table 3. Angle of repose less than 250 
indicates excellent flow. Carr’s compressibility 
index value in the range 5–15% indicates excellent 
flow and in the range 16–21% indicates fair to good 
flow. Angle of repose value of all the products 
tested were < 250 indicating excellent flow of 
prosolve and all the tablet granulations tested. 
Whereas compressibility index values of the 
products tested were in the range 9–21 % indicating 
fair to good flow. As prosolve and the tablet 
granulations (the blend of prosolve and other 
ingredients) exhibited excellent to good flow 
characteristics, they are considered suitable for 
direct compression method.  
 The hardness of the tablets prepared was 
in the range of 6 – 8 kg/cm2 Weight loss in the 
friability test was less than 1.0 % in all the cases. 
The tablets contained drug within 100±3 % of the 
labeled claim. All the formulated tablets of 
piroxicam, celecoxib and aceclofenac disintegrated 
within 18 seconds. As such all the tablets 
formulated employing prosolve are of good quality 
fulfilling the official (I.P) requirements with regard 
to drug content, hardness, friability and 
disintegration time.Dissolution parameters of the 
formulated tablets are summarized in Table 2. All 
the tablets formulated employing prosolve gave 
rapid and higher dissolution than the commercial 
products with all three drugs. Drug dissolution from 
the tablets followed first order kinetics. A 2 to 5 fold 
increase in the dissolution rate (K1) was observed 
with formulated tablets when compared to 
commercial tablets. Three disintegrants namely 
pregelatinised starch, sodium starch glycolate and 
croscarmellose sodium were used in each case. With 
all the three drugs tablets formulated employing 
sodium starch glycolate gave higher dissolution 
rates and DE30 values than those formulated with 
pregelatinised starch and croscarmellose sodium. 
The compared DE30% values with commercial 
products can be seen in figure 1, figure 2 and figure 
3 respectively. The order of performance of 
disintegrants in enhancing the dissolution rate was 
sodium starch glycolate > croscarmellose sodium > 
pregelatinised starch in the case of piroxicam and 
aceclofenac and sodium starch glycolate > 
pregelatinised starch > croscarmellose sodium in the 
case of celecoxib.  
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Prosolve, a new directly compressible vehicle and 
other tablet ingredients exhibited excellent to good 
flow needed for direct compression. Tablets 
formulated employing prosolve gave 2 to 5 fold 
increase in the dissolution rate with piroxicam, 
celecoxib and aceclofenac when compared with 
commercial tablets. Thus, prosolve could be used as 
directly compressible vehicle to prepare piroxicam, 
celecoxib and aceclofenac tablets and the tablets 
employing prosolve gave higher dissolution rates 
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